• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比较正常和缺血心肌小鼠中聚乙二醇化麦冬多糖的组织分布。

Comparison of tissue distribution of a PEGylated Radix Ophiopogonis polysaccharide in mice with normal and ischemic myocardium.

机构信息

Engineering Research Center of Modern Preparation Technology of TCM of Ministry of Education, Shanghai University of Traditional Chinese Medicine, Shanghai, PR China.

出版信息

Eur J Pharm Biopharm. 2011 Nov;79(3):621-6. doi: 10.1016/j.ejpb.2011.07.002. Epub 2011 Jul 19.

DOI:10.1016/j.ejpb.2011.07.002
PMID:21784151
Abstract

PEGylation was found to be a promising approach to improve the anti-myocardial ischemic activity of Radix Ophiopogonis polysaccharide (ROP) by prolonging its retention in plasma. To fully evaluate the effectiveness and safety of this strategy, the tissue distribution of PEGylated ROP was investigated in this study. A long-circulating and bioactive PEGylated ROP with 1.04 mol 20-kDa mPEG per mol ROP ((1.04)P(20k)-R) was prepared by a moderate coupling reaction between the hydroxyl-activated ROP and the amino-terminated mPEG. Its tissue distribution in mice with normal and ischemic myocardium was studied and compared with ROP. The results show that the descending order of tissue distribution of (1.04)P(20k)-R ranked by AUC was kidney, lung, heart, liver, and brain in normal mice and kidney ≈ lung ≈ heart, liver and brain in mice with myocardial ischemia. With the exception of the heart, myocardial ischemia did not cause obvious changes in the distribution of (1.04)P(20k)-R in the other tissues studied. Owing to the enhanced permeability and retention effect caused by ischemia, the AUC of (1.04)P(20k)-R in ischemic hearts was approximately 1.6-fold greater than in normal hearts. Compared with ROP in rats, the distribution tendency of (1.04)P(20k)-R in mouse kidney, brain, and lung was reduced by approximately 42, 1.6, and 1.3 times, respectively, whereas it was increased by approximately 1.3-fold in the liver. The results of this study are highly instructive for the further pharmaceutical development of PEGylated ROP.

摘要

聚乙二醇化被发现是一种有前途的方法,可以通过延长其在血浆中的保留时间来提高芦根多糖的抗心肌缺血活性。为了充分评估这种策略的有效性和安全性,本研究考察了聚乙二醇化芦根多糖的组织分布。通过羟基活化的芦根多糖与氨基末端的 20kDa mPEG 的适度偶联反应,制备了一种具有长循环和生物活性的 1.04mol 20kDa mPEG 每摩尔芦根多糖的聚乙二醇化芦根多糖((1.04)P(20k)-R)。研究了其在正常和缺血心肌小鼠中的组织分布,并与芦根多糖进行了比较。结果表明,(1.04)P(20k)-R 在正常小鼠中的组织分布 AUC 排序降序依次为肾、肺、心、肝和脑,而在心肌缺血小鼠中为肾≈肺≈心、肝和脑。除心脏外,心肌缺血未引起研究的其他组织中(1.04)P(20k)-R 的分布发生明显变化。由于缺血引起的通透性和滞留效应增强,(1.04)P(20k)-R 在缺血心脏中的 AUC 约为正常心脏的 1.6 倍。与大鼠中的芦根多糖相比,(1.04)P(20k)-R 在小鼠肾、脑和肺中的分布趋势分别降低了约 42、1.6 和 1.3 倍,而在肝脏中的分布增加了约 1.3 倍。本研究的结果对聚乙二醇化芦根多糖的进一步药物开发具有重要的指导意义。

相似文献

1
Comparison of tissue distribution of a PEGylated Radix Ophiopogonis polysaccharide in mice with normal and ischemic myocardium.比较正常和缺血心肌小鼠中聚乙二醇化麦冬多糖的组织分布。
Eur J Pharm Biopharm. 2011 Nov;79(3):621-6. doi: 10.1016/j.ejpb.2011.07.002. Epub 2011 Jul 19.
2
Poly(ethylene glycol)-radix Ophiopogonis polysaccharide conjugates: preparation, characterization, pharmacokinetics and in vitro bioactivity.聚乙二醇-麦冬多糖缀合物的制备、表征、药代动力学和体外生物活性。
Eur J Pharm Biopharm. 2010 Oct;76(2):230-7. doi: 10.1016/j.ejpb.2010.07.003. Epub 2010 Jul 13.
3
Mono-PEGylated radix ophiopogonis polysaccharide for the treatment of myocardial ischemia.单 PEG 化麦冬多糖治疗心肌缺血。
Eur J Pharm Sci. 2013 Jul 16;49(4):629-36. doi: 10.1016/j.ejps.2013.05.020. Epub 2013 May 29.
4
Long-circulating delivery of bioactive polysaccharide from radix ophiopogonis by PEGylation.通过 PEG 化实现麦冬多糖的长循环递药。
Int J Nanomedicine. 2011;6:2865-72. doi: 10.2147/IJN.S26306. Epub 2011 Nov 11.
5
PEGylation for drug delivery to ischemic myocardium: pharmacokinetics and cardiac distribution of poly(ethylene glycol)s in mice with normal and ischemic myocardium.聚乙二醇化用于向缺血性心肌递药:正常和缺血性心肌小鼠中聚乙二醇的药代动力学和心脏分布。
Eur J Pharm Sci. 2012 Aug 15;46(5):545-52. doi: 10.1016/j.ejps.2012.04.010. Epub 2012 Apr 16.
6
Injectable long-acting systems for Radix Ophiopogonis polysaccharide based on mono-PEGylation and in situ formation of a PLGA depot.基于单聚乙二醇化和聚乳酸-羟基乙酸共聚物(PLGA)原位形成储库的麦冬多糖注射用长效制剂。
Int J Nanomedicine. 2014 Nov 28;9:5555-63. doi: 10.2147/IJN.S71819. eCollection 2014.
7
Targeting delivery of Radix Ophiopogonis polysaccharide to ischemic/reperfused rat myocardium by long-circulating macromolecular and liposomal carriers.通过长循环大分子和脂质体载体将麦冬多糖靶向递送至缺血/再灌注大鼠心肌。
Int J Nanomedicine. 2015 Sep 10;10:5729-37. doi: 10.2147/IJN.S89445. eCollection 2015.
8
Increased cardiac distribution of mono-PEGylated Radix Ophiopogonis polysaccharide in both myocardial infarction and ischemia/reperfusion rats.单聚乙二醇化麦冬多糖在心肌梗死和缺血/再灌注大鼠心脏中的分布增加。
Int J Nanomedicine. 2015 Jan 9;10:409-18. doi: 10.2147/IJN.S73462. eCollection 2015.
9
[Pharmacokinetics of a long-circulating PEGylated Radix Ophiopogonis polysaccharide].[一种长循环聚乙二醇化麦冬多糖的药代动力学]
Yao Xue Xue Bao. 2011 Oct;46(10):1257-61.
10
[Comparison of distribution of Ophiopogon japonicas polysaccharide in hearts of normal rats and myocardial ischemic rats].[麦冬多糖在正常大鼠与心肌缺血大鼠心脏中的分布比较]
Zhongguo Zhong Yao Za Zhi. 2009 Jan;34(2):230-3.

引用本文的文献

1
Extraction, purification, structural characterization, bioactivities, modifications and structure-activity relationship of polysaccharides from : a review.来自……的多糖的提取、纯化、结构表征、生物活性、修饰及构效关系:综述
Front Nutr. 2024 Nov 13;11:1484865. doi: 10.3389/fnut.2024.1484865. eCollection 2024.
2
In Vivo Tissue Distribution and Pharmacokinetics of FITC-Labelled Polyphenol-Polysaccharide Complex in Mice.异硫氰酸荧光素标记的多酚 - 多糖复合物在小鼠体内的组织分布及药代动力学
Foods. 2024 Sep 23;13(18):3019. doi: 10.3390/foods13183019.
3
Pharmacokinetics and Excretion Study of   Polysaccharides in Rats by FITC-Fluorescence Labeling.
异硫氰酸荧光素标记法对大鼠体内多糖的药代动力学及排泄研究
Foods. 2021 Nov 18;10(11):2851. doi: 10.3390/foods10112851.
4
Atrial natriuretic peptide modified oleate adenosine prodrug lipid nanocarriers for the treatment of myocardial infarction: in vitro and in vivo evaluation.用于治疗心肌梗死的心房利钠肽修饰油酸腺苷前药脂质纳米载体:体外和体内评价
Drug Des Devel Ther. 2018 Jun 11;12:1697-1706. doi: 10.2147/DDDT.S166749. eCollection 2018.
5
Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo.氧化还原响应性和pH敏感性纳米颗粒增强了厄洛替尼在体内治疗肺癌的稳定性和抗癌能力。
Drug Des Devel Ther. 2017 Dec 8;11:3519-3529. doi: 10.2147/DDDT.S151422. eCollection 2017.
6
Drug delivery for bioactive polysaccharides to improve their drug-like properties and curative efficacy.生物活性多糖的药物传递以改善其类药性和治疗效果。
Drug Deliv. 2017;24(sup1):70-80. doi: 10.1080/10717544.2017.1396383.
7
Microanalysis, Pharmacokinetics and Tissue Distribution of Polysaccharide-Protein Complexes from Longan Pulp in Mice.龙眼果肉多糖 - 蛋白质复合物在小鼠体内的微量分析、药代动力学及组织分布
Int J Mol Sci. 2015 Oct 15;16(10):24403-16. doi: 10.3390/ijms161024403.
8
Targeting delivery of Radix Ophiopogonis polysaccharide to ischemic/reperfused rat myocardium by long-circulating macromolecular and liposomal carriers.通过长循环大分子和脂质体载体将麦冬多糖靶向递送至缺血/再灌注大鼠心肌。
Int J Nanomedicine. 2015 Sep 10;10:5729-37. doi: 10.2147/IJN.S89445. eCollection 2015.
9
Increased cardiac distribution of mono-PEGylated Radix Ophiopogonis polysaccharide in both myocardial infarction and ischemia/reperfusion rats.单聚乙二醇化麦冬多糖在心肌梗死和缺血/再灌注大鼠心脏中的分布增加。
Int J Nanomedicine. 2015 Jan 9;10:409-18. doi: 10.2147/IJN.S73462. eCollection 2015.
10
Long-circulating delivery of bioactive polysaccharide from radix ophiopogonis by PEGylation.通过 PEG 化实现麦冬多糖的长循环递药。
Int J Nanomedicine. 2011;6:2865-72. doi: 10.2147/IJN.S26306. Epub 2011 Nov 11.